What is the recommended ciprofloxacin (Cipro) dose for an ENT infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ciprofloxacin Dosing for ENT Infections

For most ENT infections requiring ciprofloxacin, use 500-750 mg orally twice daily for adults, with specific dosing depending on the infection type and severity.

Dosing by Infection Type

Acute Otitis Externa (Outer Ear Canal Infection)

  • Topical ciprofloxacin 0.3% otic drops is the preferred route 1
  • Oral dosing: 500 mg twice daily if systemic therapy needed 2, 3
  • Topical therapy is significantly more effective than oral for ear infections 4, 5, 6

Chronic Suppurative Otitis Media (Middle Ear Infection with Perforation)

  • Topical ciprofloxacin 0.2-0.5% drops twice daily for 5-10 days 4, 5
  • If oral therapy required: 250-500 mg twice daily 5, 7
  • Critical point: Topical administration achieves 95% bacteriological eradication versus only 40% with oral therapy 5
  • For chronic otitis, topical therapy demonstrates superior outcomes compared to systemic administration 6

Malignant External Otitis (Severe Pseudomonas Infection)

  • 750 mg orally twice daily for approximately 3 months 8
  • Alternative: 200 mg IV twice daily for severe cases 8
  • This serious infection requires prolonged therapy with 96.4% clinical cure rate at this dosing 8

Pharyngotonsillitis (Throat Infection)

  • 250 mg orally twice daily for 5-10 days 9
  • Reserve for cases where conventional antibiotics have failed due to resistance
  • Achieves 92% favorable clinical response 9

Bite Wounds (Animal or Human)

  • 500-750 mg orally twice daily 2, 3
  • Alternative: 400 mg IV every 12 hours 2, 3
  • Provides excellent activity against Pasteurella multocida (animal bites) and Eikenella corrodens (human bites)

Pediatric Dosing

For children when fluoroquinolones are necessary (despite FDA cautions):

  • 10-15 mg/kg every 12 hours orally (maximum 1 g/day) 10, 11
  • 20-30 mg/kg/day IV divided every 8-12 hours (maximum 400 mg/dose) 11

Key Clinical Considerations

Route selection matters significantly: For ear infections, topical ciprofloxacin achieves bacteriological eradication rates of 83-95% compared to only 40-65% with oral therapy 4, 5. The assumption that high topical concentrations overcome resistance is incorrect—ciprofloxacin-resistant bacteria show only 2.7% cure with topical ciprofloxacin versus 70% with alternative agents 12.

Resistance patterns: If ciprofloxacin resistance is documented, switch to alternative therapy immediately. Continuing ciprofloxacin (even topically) against resistant organisms is ineffective 12. The most common resistant organisms in ENT infections are MRSA (33%), Corynebacterium striatum (19%), and non-MRSA Staphylococcus aureus (11%) 12.

Duration: Most acute ENT infections require 5-10 days of therapy 4, 5, 9, except malignant external otitis which requires approximately 3 months 8.

Common pitfall: Do not use oral ciprofloxacin as first-line for simple ear infections when topical therapy is appropriate—you'll achieve worse outcomes with unnecessary systemic exposure and resistance risk 5, 6.

References

Research

[Use of topical ciprofloxacin in chronic suppurating otitis media].

Acta otorrinolaringologica espanola, 2003

Research

Topical versus systemic antibiotics for chronic suppurative otitis media.

The Cochrane database of systematic reviews, 2021

Research

Oral ciprofloxacin for treatment of acute bacterial pharyngotonsillitis.

Journal of chemotherapy (Florence, Italy), 1990

Research

Treatment of Ciprofloxacin-resistant Ear Infections.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.